CVS HEALTH CORPORATION (CVS)

93.06 +0.15% (+0.14)

Over 1M: -10.9%

2026-08-28
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

95 100 105
31 Jul 5 Aug 10 Aug 13 Aug 18 Aug 21 Aug 26 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '23 — Revenue: 89.8B Q3 '23 — Operating Cash Flow: 2.7B Q3 '23 — Free Cash Flow: 2.2B Q3 '23 — Net Income: 2.3B Q4 '23 — Revenue: 93.8B Q4 '23 — Net Income: 2B Q1 '24 — Revenue: 88.4B Q1 '24 — Operating Cash Flow: 4.9B Q1 '24 — Free Cash Flow: 4.2B Q1 '24 — Net Income: 1.1B Q2 '24 — Revenue: 91.2B Q2 '24 — Operating Cash Flow: 3.1B Q2 '24 — Free Cash Flow: 2.5B Q2 '24 — Net Income: 1.8B Q3 '24 — Revenue: 95.4B Q3 '24 — Operating Cash Flow: -745M Q3 '24 — Free Cash Flow: -1.4B Q3 '24 — Net Income: 87M Q4 '24 — Revenue: 97.7B Q4 '24 — Operating Cash Flow: 1.9B Q4 '24 — Free Cash Flow: 1.1B Q4 '24 — Net Income: 1.6B Q1 '25 — Revenue: 94.6B Q1 '25 — Operating Cash Flow: 4.6B Q1 '25 — Free Cash Flow: 3.8B Q1 '25 — Net Income: 1.8B Q2 '25 — Revenue: 98.9B Q2 '25 — Operating Cash Flow: 1.9B Q2 '25 — Free Cash Flow: 1.3B Q2 '25 — Net Income: 1B Q3 '25 — Revenue: 102.9B Q3 '25 — Operating Cash Flow: 796M Q3 '25 — Free Cash Flow: 98M Q3 '25 — Net Income: -4B Q4 '25 — Revenue: 105.7B Q4 '25 — Operating Cash Flow: 3.4B Q4 '25 — Free Cash Flow: 2.6B Q4 '25 — Net Income: 2.9B Q1 '26 — Revenue: 100.4B Q1 '26 — Operating Cash Flow: 4.2B Q1 '26 — Free Cash Flow: 3.4B Q1 '26 — Net Income: 2.9B Q2 '26 — Revenue: 106.1B Q2 '26 — Operating Cash Flow: 6.3B Q2 '26 — Free Cash Flow: 5.7B Q2 '26 — Net Income: 3B 0 25B 50B 75B 100B 125B
Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

3.1
SBC / sales 0.17%
OE margin 2.7%
ROIC 5.1%
Accruals -3.9%
OCF / EBIT 1.8×
Gross margin 44.5%
ROA 1.9%
ROCE 5.0%
FCF margin 2.8%
OCF margin 3.6%
ROE 6.1%

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

5.5
RPO / sales 0.00015×
RPO growth —
Segment HHI —

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

1.6
ND/EBITDA —
Current ratio 0.87×
F-score 7.0 pts
Cash / Debt 0.23×
Debt / Eq 0.77×
Debt payback 4.0 yr
Payout 69.9%
Quick ratio 0.66×
Cash runway —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

2.8
Sales/sh Y/Y +6.6%
Shares change +0.71%
EPS Y/Y +7.2%
Sales Q/Q +7.3%
Div. growth +0.71%
EBIT CAGR +1.2%
EBIT Y/Y -7.4%
EPS CAGR 4Y -30.7%
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.